Furthermore, research based on the non-DTCs (such as hepatic cellular cancer, lung cancer, breast cancer etc.)should be performed to explore the association between PLCE1 gene polymorphisms and cancer risks. This evidence concerns the gene PLCE1 and breast carcinoma.